Procalcitonin as a biomarker of cardiac implantable electronic device pocket infection: a prospective validation study

Back

EHRA Premium Access

Procalcitonin as a biomarker of cardiac implantable electronic device pocket infection: a prospective validation study

Session: ePosters Day 2

Topic: Device Complications and Lead Extraction

Speaker: Miss K. Knoll (Munich, DE)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Miss Katharina Knoll

German Heart Center Muenchen Technical University of Munich, Munich (Germany)

1 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Access

Abstract

Slides

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Access

Abstract

Slides

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)

Access

Abstract

Slides

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

Access

Abstract

Slides

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Access

Abstract

Slides

Access the full session

ePosters Day 2

Speakers: Miss K. Knoll, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...

Access

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources